This topic contains a solution. Click here to go to the answer

Author Question: A patient has begun taking quinine (Quinamm). Review the following symptoms and choose the one that ... (Read 46 times)

cdr_15

  • Hero Member
  • *****
  • Posts: 546
A patient has begun taking quinine (Quinamm). Review the following symptoms and choose the one that the patient will likely find alleviated.
 
  a. Pain due to sprained ankle
  b. Nocturnal leg cramps
  c. Back pain
  d. Neck pain

Question 2

Which of the following adverse effects are characteristic of centrally acting skeletal muscle re-laxants?
 
  a. Sedation and drowsiness
  b. Weight gain and fever
  c. Irritability and restlessness
  d. Increased blood pressure and decreased pulse



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bigcheese9

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

ANS: B
Quinine is still used in the management of nocturnal leg cramps.

Answer to Question 2

ANS: A
Common adverse effects of centrally acting skeletal muscle relaxants are sedation, drowsiness, lightheadedness, ataxia, and dizziness.




cdr_15

  • Member
  • Posts: 546
Reply 2 on: Jul 23, 2018
:D TYSM


shewald78

  • Member
  • Posts: 340
Reply 3 on: Yesterday
Excellent

 

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library